Terns Pharmaceuticals Inc (TERN)
5.79
+0.08
(+1.40%)
USD |
NASDAQ |
Nov 22, 16:00
5.79
0.00 (0.00%)
After-Hours: 20:00
Terns Pharmaceuticals Shareholders Equity (Quarterly): 364.47M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 364.47M |
| June 30, 2024 | 218.68M |
| March 31, 2024 | 236.72M |
| December 31, 2023 | 255.37M |
| September 30, 2023 | 258.42M |
| June 30, 2023 | 274.15M |
| March 31, 2023 | 287.68M |
| December 31, 2022 | 276.94M |
| September 30, 2022 | 183.69M |
| Date | Value |
|---|---|
| June 30, 2022 | 137.22M |
| March 31, 2022 | 148.72M |
| December 31, 2021 | 160.30M |
| September 30, 2021 | 172.16M |
| June 30, 2021 | 181.33M |
| March 31, 2021 | 190.00M |
| December 31, 2020 | 68.59M |
| September 30, 2020 | -24.85M |
| December 31, 2019 | 4.207M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-24.85M
Minimum
Sep 2020
364.47M
Maximum
Sep 2024
188.54M
Average
186.85M
Median
Shareholders Equity (Quarterly) Benchmarks
| Eli Lilly and Co | 14.24B |
| Viking Therapeutics Inc | 911.45M |
| Biomarin Pharmaceutical Inc | 5.413B |
| Elite Pharmaceuticals Inc | 47.27M |
| Verrica Pharmaceuticals Inc | -34.05M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 378.23M |
| Total Liabilities (Quarterly) | 13.76M |